HomeTPST • NASDAQ
Tempest Therapeutics Inc
add
$0.71
3.17%
Pre-market:(0.45%)+0.0032
$0.72
Closed: Apr 2, 12:30:38 AM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.55M | 60.06% |
Net income | -10.56M | -55.56% |
Net profit margin | — | — |
Earnings per share | -0.41 | 14.58% |
EBITDA | -10.45M | -60.73% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 22.12M | 98.92% |
Total assets | 33.84M | 41.06% |
Total liabilities | 22.38M | -11.11% |
Total equity | 11.46M | — |
Shares outstanding | 43.64M | — |
Price to book | 1.72 | — |
Return on assets | -69.41% | — |
Return on capital | -79.46% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -10.56M | -55.56% |
Cash from operations | -10.18M | -56.96% |
Cash from investing | -15.00K | — |
Cash from financing | 1.54M | 7,238.10% |
Net change in cash | -8.66M | -33.87% |
Free cash flow | -6.73M | -67.28% |
Previous close
$0.74
Day range
$0.70 - $0.75
Year range
$0.70 - $6.00
Market cap
32.41M USD
Avg Volume
532.41K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2011
Headquarters
Website
Employees
24
